Frenkel Topping Group has reported strong growth in its socially responsible investment portfolio, testament to the millennial appetite for socially responsible investing (SRI) and bucking the current global trend towards economic downturn.
With a collective USD30 trillion global wealth transfer from baby boomers to their millennial children, and with 90 per cent of millennials seeking to grow their allocation to responsible investments in the next five years, this sharp trajectory is set to continue.
Furthermore, according to the same report, 15 per cent of millennials would exit an investment position due to objectionable firm activity, compared with 7 per cent of non-millennial investors.
Richard Fraser, CEO of Frenkel Topping Group, says: “The millennial mindset is here to stay. While some businesses took an initial view that this was a fad, we realised early on the significant growth potential of socially responsible investing.
“We were one of the first to market with a new SRI portfolio that demonstrated a blend of the best environmental, social and governance practices. In a market that is calling for regulators to close the gap between what issuers disclose and what investors want,[2] we are already a long way ahead of the pack.
“Millennials are used to having a wealth of information at their fingertips, and expect the same from their investment management. Transparency of information and ethical investment are prioritised by this next generation of investors.
“We have seen a rising number of enquiries from clients who are looking for long-term asset growth through investment that achieves a positive impact, rather than that necessarily delivers the highest return in the short term.
“What we are seeing now is this approach paying off on all fronts. The Frenkel Topping Group SRI portfolio is outperforming its benchmark and this trend is demonstrating marked growth.”
Frenkel Topping Group manages the financial assets of people who have suffered catastrophic injuries, including those awarded large compensation payments through personal injury or clinical negligence claims.
